Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Long-term Safety, Tolerability, and Efficacy of KarXT for schizophrenia.
Multiple locations, including Little RockThis study was terminated in the United States. It is testing Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT for schizophrenia.
Multiple locations, including AtlantaThis study is completed. It focuses on Bipolarity.
Location not clearly listedThis study is completed in the United States. It focuses on anxiety.
In BostonThis study is completed in the United States. It focuses on PTSD.
In OmahaThis study is completed in the United States. It focuses on Eating disorders.
In BelmontThis study is completed in the United States. It focuses on Schizophrenia.
In Medford
This study was withdrawn. It focuses on Addiction.
Location not clearly listedThis study is completed in the United States. It is testing Open-Label Trial of Tocilizumab for schizophrenia.
In AugustaThis study is completed in the United States, in the United Kingdom, in Croatia, .... It focuses on schizophrenia.
Multiple locations, including Los AlamitosThis study is ongoing in France, in Belgium, in Sweden, .... It is testing aticaprant for depression.
In SwedenThis study is completed in the United Kingdom, in Belgium, in Sweden, .... It is testing intranasal Esketamine for treatment-resistant depression.
In SwedenHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.